Correlation Between Mekonomen and Cell Impact

Can any of the company-specific risk be diversified away by investing in both Mekonomen and Cell Impact at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mekonomen and Cell Impact into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mekonomen AB and Cell Impact AB, you can compare the effects of market volatilities on Mekonomen and Cell Impact and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mekonomen with a short position of Cell Impact. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mekonomen and Cell Impact.

Diversification Opportunities for Mekonomen and Cell Impact

0.02

Correlation Coefficient

Mekonomen  Cell Impact

Significant diversification

The 3 months correlation between Mekonomen and Cell is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Mekonomen AB and Cell Impact AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Impact AB and Mekonomen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mekonomen AB are associated (or correlated) with Cell Impact. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Impact AB has no effect on the direction of Mekonomen i.e., Mekonomen and Cell Impact go up and down completely randomly.

Pair Corralation between Mekonomen and Cell Impact

Assuming the 90 days trading horizon Mekonomen AB is expected to generate 0.35 times more return on investment than Cell Impact. However, Mekonomen AB is 2.88 times less risky than Cell Impact. It trades about 0.02 of its potential returns per unit of risk. Cell Impact AB is currently generating about -0.09 per unit of risk. If you would invest  13,198  in Mekonomen AB on September 2, 2024 and sell it today you would earn a total of  122.00  from holding Mekonomen AB or generate 0.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mekonomen AB  vs.  Cell Impact AB

Mekonomen AB

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mekonomen AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mekonomen is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Cell Impact AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cell Impact AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Mekonomen and Cell Impact

The main advantage of trading using opposite Mekonomen and Cell Impact positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mekonomen position performs unexpectedly, Cell Impact can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Impact will offset losses from the drop in Cell Impact's long position.

The idea behind Mekonomen AB and Cell Impact AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.